Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/165174
Title: | mRNA Detection in Anal Cytology: A Feasible Approach for Anal Cancer Screening in Men Who Have Sex with Men Living With HIV |
Author: | Pino Saladrigues, Marta del Martí Delgado, Cristina Gaber, Jina Svanholm-Barrie, Cecilia Rodríguez-Carunchio, Leonardo Rodríguez Trujillo, Adriano Carreras, Núria Fuertes, Irene Barnadas, Esther Marimon, Lorena Blanco, José L. Persing, David H. Torné Bladé, Aureli Ordi i Majà, Jaume |
Keywords: | Càncer colorectal Citologia RNA Marcadors bioquímics Colorectal cancer Cytology RNA Biochemical markers |
Issue Date: | 2-Nov-2019 |
Publisher: | MDPI |
Abstract: | There is growing interest in anal cancer screening strategies. However, cytological/molecular evaluation of anal samples is challenging. We aimed to determine the feasibility of detecting, in anal liquid-based cytologies, the expression of biomarkers involved in the cell cycle disturbance elicited by human papillomavirus (HPV). The accuracy of this approach in the identification of high-grade squamous intraepithelial lesions/anal intraepithelial neoplasia grade2-3 (HSIL/AIN2-3) was also evaluated. 215 anal cytologies from men having sex with men living with human immunodeficiency virus were evaluated. Patients showing concordant cytological and anoscopy-directed biopsy diagnosis were selected: 70 with negative cytology and HPV test, 70 with low-grade SIL (LSIL/AIN1) cytology and biopsy, and 75 with cytology and biopsy of HSIL/AIN2-3. CDKN2A/p16, MKI67 and TOP2A mRNA expression was analyzed. HPV detection was performed with Xpert HPV Assay (Cepheid, Sunnyvale, CA, USA). HSIL/AIN2-3 showed higher expression for the biomarkers than LSIL/AIN1 or negative samples. The specificity for HSIL/AIN2-3 detection for a sensitivity established at 70% was 44.7% (95%confidence interval [CI] 36.5-53.2) for TOP2A and MKI67 and 54.5% (95%CI 46.0-62.8%) for CDKN2A/p16. mRNA detection of cell biomarkers in anal liquid-based cytology is feasible. Further studies are warranted to confirm if strategies based on mRNA detection have any role in anal cancer screening. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/diagnostics9040173 |
It is part of: | Diagnostics, 2019, vol. 9, num. 4, p. 191 |
URI: | http://hdl.handle.net/2445/165174 |
Related resource: | https://doi.org/10.3390/diagnostics9040173 |
ISSN: | 2075-4418 |
Appears in Collections: | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
695640.pdf | 1.37 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License